A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine

PHASE3CompletedINTERVENTIONAL

Enrollment

1,197

Participants

Timeline

Start Date

April 7, 2014

Primary Completion Date

May 20, 2017

Study Completion Date

September 14, 2017

Conditions

Varicella

Interventions

BIOLOGICAL

Vaccine manufactured at commercialized scale

Single subcutaneous injection of the investigated live attenuated varicella vaccine (0.5 ml) on Day 0

BIOLOGICAL

Vaccine manufactured at trial-scale

Single subcutaneous injection of the control live attenuated varicella vaccine (0.5 ml) on Day 0

All Listed Sponsors

lead

Sinovac (Dalian) Vaccine Technology Co., Ltd.

INDUSTRY

NCT03555071 - A Phase 3 Lot-consistency Clinical Trial of Live Attenuated Varicella Vaccine | Biotech Hunter | Biotech Hunter